Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

NCT02923557 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT02923557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02923557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients
Lead sponsor
Peking University First Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2016
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder recurrence, nephroureterectomy, upper tract urothelial carcinoma